|
AK2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
3.79949999995688E-06 |
| Normal-vs-Stage3 |
2.27839969113575E-10 |
| Normal-vs-Stage4 |
2.396800E-03 |
| Stage1-vs-Stage2 |
7.296600E-01 |
| Stage1-vs-Stage3 |
7.702400E-01 |
| Stage1-vs-Stage4 |
3.566000E-01 |
| Stage2-vs-Stage3 |
6.449400E-01 |
| Stage2-vs-Stage4 |
6.307400E-01 |
| Stage3-vs-Stage4 |
3.367600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
6.66133814775094E-16 |
| Normal-vs-Asian |
4.522200E-02 |
| Caucasian-vs-AfricanAmerican |
7.770400E-01 |
| Caucasian-vs-Asian |
7.931800E-01 |
| AfricanAmerican-vs-Asian |
9.070800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.406600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.68419747434723E-11 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.90469862104692E-12 |
| Normal-vs-Extreme_Obese |
6.217000E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.068000E-01 |
| Normal_Weight-vs-Obese |
9.571200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.794200E-01 |
| Extreme_Weight-vs-Obese |
3.963200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.161240E-01 |
| Obese-vs-Extreme_Obese |
4.621200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.47264447700491E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.082900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.670000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.742000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.464200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.370430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.156400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.777800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.36319999954893E-07 |
| Normal-VS-KIRP CIMP |
1.47070000622307E-09 |
| Normal-VS-Unclassified PRCC |
1.62447832963153E-12 |
| Type1 PRCC-VS-Type2 PRCC |
1.056450E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.640200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.350000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.032300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.004400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.025800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.75209974201596E-10 |
| Normal-vs-N1 |
2.81885625952327E-13 |
| Normal-vs-N2 |
7.426400E-02 |
| N0-vs-N1 |
1.240950E-01 |
| N0-vs-N2 |
7.378800E-01 |
| N1-vs-N2 |
6.603400E-01 |
|
|
